MARKETS

Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting

Kgaogelo MatshwiKgaogelo Matshwi
Apr 30, 2024 - 18:21
 0  1
Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
Read More

Tags:

Previous Article

Roborock Teams Up with "The Garfield Movie" to Give Garfield a More Pampered Life

Next Article

CHINA NATURAL RESOURCES REPORTS FULL YEAR 2023 RESULTS

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Kgaogelo Matshwi
Kgaogelo Matshwi

Related Posts

Balance of Power 04/22/24

Balance of Power 04/22/24

Kgaogelo Matshwi Apr 23, 2024  0  0

Traders Expect Biggest Fed-Day Move in S&P Since 2023, Citi Says

Traders Expect Biggest Fed-Day Move in S&P Since 20...

Kgaogelo Matshwi Apr 30, 2024  0  11

Veolia: Combined Shareholders' General Meeting, April 25, 2024

Veolia: Combined Shareholders' General Meeting, April 2...

Kgaogelo Matshwi Apr 25, 2024  0  6